Kwei Lan Tsao

Statistics

Publications

Citations

175

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Merck Serono Ltd. (United Kingdom)

Kwei Lan Tsao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1992–2010

Publications

Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP.

Julie E. Scheffler, David S. Waugh, Eva Bekesi et al. · Journal of Biological Chemistry · 1994 · 58 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists

Jason Elliott, Robert W. Carling, Mark S. Chambers et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor

Gregori J. Morriello, Gary G. Chicchi, Tricia L. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +4

NK1 antagonists based on seven membered lactam scaffolds

Jason Elliott, Emma Carlson, Gary G. Chicchi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II

Jason Elliott, Robert W. Carling, Gary G. Chicchi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +9

1–5 of 7